Stockholm, August 15, 2011 — NASDAQ OMX (NASDAQ:NDAQ) announces that the trading in Episurf Medical AB (EPIS B) shares commenced today on First North at NASDAQ OMX Stockholm. Episurf Medical belongs to the health care sector and is the ninth Company to be admitted to trading on First North in 2011, and the eleventh company to move to NASDAQ OMX from Aktietorget.
Episurf is a medical technology company specializing in the development and commercialization of personalized products for the repair of local cartilage damage in human joints.
Nina Bake, CEO, Episurf Medical AB commented: “Our move to First North is a first step and we eventually aim for a move to the Small Cap segment on the main market. Our listing with NASDAQ OMX gives us increased exposure towards both private and institutional investors needed in order to support our continued growth.”
Jenny Rosberg, Senior Vice President, NASDAQ OMX said: “We welcome Episurf to First North where they will make a great addition to our health care sector. We continue to see a strong inflow of companies switching to First North where we have already matched last year’s number of listings. First North acts as a stepping stone to our Nordic main market and is today the most liquid growth market in Europe.”
Episurf Medical has appointed Öhman Fondkommission as Certified Adviser.